BRPI9813397B8 - formulação medicinal em aerossol e produto medicinal. - Google Patents

formulação medicinal em aerossol e produto medicinal.

Info

Publication number
BRPI9813397B8
BRPI9813397B8 BRPI9813397A BRPI9813397B8 BR PI9813397 B8 BRPI9813397 B8 BR PI9813397B8 BR PI9813397 A BRPI9813397 A BR PI9813397A BR PI9813397 B8 BRPI9813397 B8 BR PI9813397B8
Authority
BR
Brazil
Prior art keywords
medicinal
aerosol formulation
drug
product
propellant
Prior art date
Application number
Other languages
English (en)
Inventor
Yvonne Mary Beatrice King
Kanwaljit Singh Claire
Original Assignee
Minnesota Mining & Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minnesota Mining & Mfg filed Critical Minnesota Mining & Mfg
Publication of BRPI9813397A publication Critical patent/BRPI9813397A/pt
Publication of BRPI9813397B1 publication Critical patent/BRPI9813397B1/pt
Publication of BRPI9813397B8 publication Critical patent/BRPI9813397B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BRPI9813397-7 1997-12-08 1998-11-20 formulação medicinal em aerossol e produto medicinal. BRPI9813397B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9725984A GB2332372B (en) 1997-12-08 1997-12-08 Pharmaceutical aerosol compositions
PCT/GB1998/003488 WO1999029296A1 (en) 1997-12-08 1998-11-20 Pharmaceutical aerosol compositions

Publications (3)

Publication Number Publication Date
BRPI9813397A BRPI9813397A (pt) 2000-10-10
BRPI9813397B1 BRPI9813397B1 (pt) 2011-08-23
BRPI9813397B8 true BRPI9813397B8 (pt) 2021-07-06

Family

ID=10823304

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9813397-7 BRPI9813397B8 (pt) 1997-12-08 1998-11-20 formulação medicinal em aerossol e produto medicinal.

Country Status (11)

Country Link
EP (1) EP1037604B1 (pt)
JP (1) JP5384776B2 (pt)
AT (1) ATE287699T1 (pt)
AU (1) AU759746B2 (pt)
BR (1) BRPI9813397B8 (pt)
CA (1) CA2311450C (pt)
DE (1) DE69828817T2 (pt)
ES (1) ES2234165T3 (pt)
GB (1) GB2332372B (pt)
PT (1) PT1037604E (pt)
WO (1) WO1999029296A1 (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11509434A (ja) * 1995-04-14 1999-08-24 グラクソ、ウェルカム、インコーポレーテッド サルメテロール用計量投与用吸入器
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US6423298B2 (en) 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
CA2317999C (en) * 1999-09-11 2004-11-09 Glaxo Group Limited Pharmaceutical formulation of fluticasone propionate
EP1248597B1 (en) * 1999-12-24 2005-03-30 Glaxo Group Limited Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
US20040191176A1 (en) * 2003-03-28 2004-09-30 Kaplan Leonard W Formulations for treatment of pulmonary disorders
DE102006053374A1 (de) * 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
EP2414560B1 (de) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Verfahren zur beschichtung einer oberfläche eines bauteils
EP3508239B1 (de) 2009-05-18 2020-12-23 Boehringer Ingelheim International GmbH Adapter, inhalationseinrichtung und zerstäuber
MX2012005961A (es) 2009-11-25 2012-06-14 Boehringer Ingelheim Int Nebulizador.
JP5658268B2 (ja) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
EP2512438B1 (en) * 2009-12-16 2017-01-25 3M Innovative Properties Company Formulations and methods for controlling mdi particle size delivery
JP5874724B2 (ja) 2010-06-24 2016-03-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
WO2012130757A1 (de) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
EP2835146B1 (en) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Nebulizer
WO2015018904A1 (en) 2013-08-09 2015-02-12 Boehringer Ingelheim International Gmbh Nebulizer
MX383195B (es) 2014-05-07 2025-03-13 Boehringer Ingelheim Int Recipiente, nebulizador y uso.
WO2015169430A1 (en) 2014-05-07 2015-11-12 Boehringer Ingelheim International Gmbh Nebulizer
BR122022010094B1 (pt) 2014-05-07 2023-10-03 Boehringer Ingelheim International Gmbh Dispositivo indicador e recipiente
US12053284B2 (en) 2021-11-08 2024-08-06 Satio, Inc. Dermal patch for collecting a physiological sample
US11877848B2 (en) 2021-11-08 2024-01-23 Satio, Inc. Dermal patch for collecting a physiological sample
US11964121B2 (en) 2021-10-13 2024-04-23 Satio, Inc. Mono dose dermal patch for pharmaceutical delivery
US12214346B2 (en) 2021-10-13 2025-02-04 Satio, Inc. Dermal patch with a diagnostic test strip
US12178979B2 (en) 2021-10-13 2024-12-31 Satio, Inc. Dermal patch for delivering a pharmaceutical
US12048543B2 (en) 2021-11-08 2024-07-30 Satio, Inc. Dermal patch for collecting a physiological sample with removable vial
US11452474B1 (en) 2021-04-14 2022-09-27 Satio, Inc. Dual lever dermal patch system
US12023156B2 (en) 2021-10-13 2024-07-02 Satio, Inc. Dermal patch for collecting a physiological sample

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU658854B2 (en) * 1990-10-18 1995-05-04 Minnesota Mining And Manufacturing Company Aerosol formulation comprising beclomethasone 17,21 dipropionate
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
ATE128350T1 (de) * 1991-12-12 1995-10-15 Glaxo Group Ltd Pharmazeutische aerosolformulierung.
US5589156A (en) * 1994-05-02 1996-12-31 Henry; Richard A. Prilocaine and hydrofluourocarbon aerosol preparations
GB9425160D0 (en) * 1994-12-10 1995-02-08 Glaxo Group Ltd Medicaments
EP0914143A1 (en) * 1996-07-08 1999-05-12 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation
KR100600423B1 (ko) * 1998-06-18 2006-07-13 베링거 인겔하임 파마슈티칼즈, 인코포레이티드 2개 이상의 활성 물질을 포함하는 연무질 약제학적 제형

Also Published As

Publication number Publication date
CA2311450A1 (en) 1999-06-17
EP1037604A1 (en) 2000-09-27
DE69828817T2 (de) 2006-05-18
ES2234165T3 (es) 2005-06-16
GB2332372A (en) 1999-06-23
PT1037604E (pt) 2005-05-31
JP5384776B2 (ja) 2014-01-08
JP2001525354A (ja) 2001-12-11
AU759746B2 (en) 2003-05-01
WO1999029296A1 (en) 1999-06-17
DE69828817D1 (de) 2005-03-03
EP1037604B1 (en) 2005-01-26
ATE287699T1 (de) 2005-02-15
AU1248699A (en) 1999-06-28
BRPI9813397A (pt) 2000-10-10
GB9725984D0 (en) 1998-02-04
CA2311450C (en) 2009-05-05
BRPI9813397B1 (pt) 2011-08-23
GB2332372B (en) 2002-08-14

Similar Documents

Publication Publication Date Title
BRPI9813397B1 (pt) formulação medicinal em aerossol e produto medicinal.
ATE343374T1 (de) Fluticasonpropionat arzneizubereitung
ATE291898T1 (de) Pharmazeutische aerosol formulierung enthaltend salmeterol und fluticason
NZ298169A (en) Aerosol drug formulation; comprises hydrofluoroalkane propellant, medicament for inhalation and a surfactant
GEP20053420B (en) Sustained Release Ranolanolazine Formulation
YU59092A (sh) Formulacije aerosola koji ne sadrže hlorofluorougljenična jedinjenja
NO307864B1 (no) Farmasøytisk aerosolformulering, boks og doseringsinhalator
EP1135173A4 (en) MEDICINAL AEROSOL FORMULATION
EE04021B1 (et) 7a-( -aminoalküül)östratrieenid, nende valmistamise meetod, 7a-( -aminoalküül)östratrieene sisaldavad farmatseutilised preparaadid ja nende kasutamine ravimite valmistamiseks
DK1306082T3 (da) Afmålte dosisinhalatorer under tryk og farmaceutiske aerosolformuleringer
ES2107203T3 (es) Una formulacion de aerosol que contiene un adyuvante de dispersion derivado de un diol-diacido.
NO990454D0 (no) Aerosol-materiale
NO20010277L (no) Benzocykloheptener, fremgangsmÕte for fremstilling derav, farmasøytiske preparater inneholdende disse, og deres anvendelse for fremstilling av medikamenter
NO980858D0 (no) Farmasöytiske preparater og anordninger for administrering derav
ATE202936T1 (de) Chlorfluorkohlenwasserstoff freie aerosol- arzneizubereitungen enthaltend mometasonfuroat
NO305286B1 (no) Kinoksalinforbindelser, farmas°ytiske preparater som omfatter dem, og anvendelse derav for fremstilling av medikamenter
NO308527B1 (no) Substituerte 2-naftoylguanidiner, deres anvendelse for fremstilling av et medikament samt legemidler og preparater inneholdende forbindelsene
WO2001082868A3 (en) A medicinal aerosol formulation
NO306993B1 (no) Piperidinylmetyloksyzolidin-2-on-derivater, farmasoeytiske preparater som inneholder slike, samt anvendelse av forbindelsene til fremstilling av legemidler
ATE286716T1 (de) Pharmazeutische formulierungen enthaltend salmeterol
CA2446562A1 (en) Pharmaceutical formulation of fluticasone propionate
ITBA920007A0 (it) Formulazioni farmaceutiche per la somminstrazione sistemica per via nasale degli ormoni sessuali femminili naturali e di ormoni ad attivita' estrogenica e/o progestativa sia naturali che di sintesi.
MX9707073A (es) Preparaciones de aerosol de prilocaina e hidrofluorocarbono.
AU2003300230A1 (en) Dosing aerosols containing lecithin as a surface-active substance
SI1042355T1 (en) 11beta-halogen-7alpha-substituted estratrienes, method for producing pharmaceutical preparations containing said 11beta-halogen-7alpha-substituted estratrienes and use of the same for producing medicaments